In conclusion, in sporadic MTC, the presence of an altered expression of PTTG1 and AURKA is a negative prognostic factor associated with a more aggressive course of disease (advanced stage and disease persistence). This evidence concerns the gene PTTG1 and medullary thyroid gland carcinoma.